News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

July 13, 2021

Tenaya Therapeutics Preclinical Research Supports Product Candidate for Heart Disease Indications

Link

May 20, 2021

Tenaya Therapeutics Receives Orphan Drug Designation for Genetic Hypertrophic Cardiomyopathy Gene Therapy

Link

March 1, 2021

Tenaya Therapeutics Secures $106 Million in Series C Funding

Link

May 12, 2020

Tenaya Therapeutics to Present Preclinical Data at American Society of Gene & Cell Therapy Meeting

Link

October 3, 2019

Tenaya Therapeutics Closes $92 Million Series B Financing

Link